BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31678380)

  • 1. Small-scale preparation of perfluorocarbon-nanoemulsions utilizing dual centrifugation.
    Krämer W; Schubert R; Massing U
    Int J Pharm; 2019 Dec; 572():118753. PubMed ID: 31678380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the Stability of Perfluorocarbon Nanoemulsions by Cryo-TEM Image Analysis and Dynamic Light Scattering.
    Grapentin C; Barnert S; Schubert R
    PLoS One; 2015; 10(6):e0130674. PubMed ID: 26098661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational manufacturing of functionalized, long-term stable perfluorocarbon-nanoemulsions for site-specific
    Krämer W; Grapentin C; Bouvain P; Temme S; Flögel U; Schubert R
    Eur J Pharm Biopharm; 2019 Sep; 142():114-122. PubMed ID: 31220572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple linear regression applied to predicting droplet size of complex perfluorocarbon nanoemulsions for biomedical applications.
    Lambert E; Janjic JM
    Pharm Dev Technol; 2019 Jul; 24(6):700-710. PubMed ID: 30724654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell penetrating peptide functionalized perfluorocarbon nanoemulsions for targeted cell labeling and enhanced fluorine-19 MRI detection.
    Hingorani DV; Chapelin F; Stares E; Adams SR; Okada H; Ahrens ET
    Magn Reson Med; 2020 Mar; 83(3):974-987. PubMed ID: 31631402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocytosis of a PFOB-Nanoemulsion for
    Nienhaus F; Colley D; Jahn A; Pfeiler S; Flocke V; Temme S; Kelm M; Gerdes N; Flögel U; Bönner F
    Molecules; 2019 May; 24(11):. PubMed ID: 31151162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions.
    Rapoport N; Nam KH; Gupta R; Gao Z; Mohan P; Payne A; Todd N; Liu X; Kim T; Shea J; Scaife C; Parker DL; Jeong EK; Kennedy AM
    J Control Release; 2011 Jul; 153(1):4-15. PubMed ID: 21277919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the Emulsification Process to Create an Albumin-Perfluorocarbon-(o/w) Nanoemulsion with High Shelf Life and Bioresistivity.
    Jaegers J; Haferkamp S; Arnolds O; Moog D; Wrobeln A; Nocke F; Cantore M; Pütz S; Hartwig A; Franzkoch R; Psathaki OE; Jastrow H; Schauerte C; Stoll R; Kirsch M; Ferenz KB
    Langmuir; 2022 Aug; 38(34):10351-10361. PubMed ID: 35969658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple Linear Regression Predictive Modeling of Colloidal and Fluorescence Stability of Theranostic Perfluorocarbon Nanoemulsions.
    Herneisey M; Janjic JM
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bimodal perfluorocarbon nanoemulsions for nasopharyngeal carcinoma targeting.
    Bae PK; Jung J; Lim SJ; Kim D; Kim SK; Chung BH
    Mol Imaging Biol; 2013 Aug; 15(4):401-10. PubMed ID: 23508465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-color fluorescent (near-infrared and visible) triphasic perfluorocarbon nanoemuslions.
    Patel SK; Patrick MJ; Pollock JA; Janjic JM
    J Biomed Opt; 2013 Oct; 18(10):101312. PubMed ID: 23912666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular pH measurements using perfluorocarbon nanoemulsions.
    Patrick MJ; Janjic JM; Teng H; O'Hear MR; Brown CW; Stokum JA; Schmidt BF; Ahrens ET; Waggoner AS
    J Am Chem Soc; 2013 Dec; 135(49):18445-57. PubMed ID: 24266634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of perfluorocarbon relaxation times and their influence on the optimization of fluorine-19 MRI at 3 tesla.
    Colotti R; Bastiaansen JAM; Wilson A; Flögel U; Gonzales C; Schwitter J; Stuber M; van Heeswijk RB
    Magn Reson Med; 2017 Jun; 77(6):2263-2271. PubMed ID: 27385530
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Amir N; Green D; Kent J; Xiang Y; Gorelikov I; Seo M; Blacker M; Janzen N; Czorny S; Valliant JF; Matsuura N
    Nucl Med Biol; 2017 Nov; 54():27-33. PubMed ID: 28863330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paramagnetic Fluorinated Nanoemulsions for in vivo F-19 MRI.
    Rho J; Stares E; Adams SR; Lister D; Leach B; Ahrens ET
    Mol Imaging Biol; 2020 Jun; 22(3):665-674. PubMed ID: 31482414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorous-Soluble Metal Chelate for Sensitive Fluorine-19 Magnetic Resonance Imaging Nanoemulsion Probes.
    Jahromi AH; Wang C; Adams SR; Zhu W; Narsinh K; Xu H; Gray DL; Tsien RY; Ahrens ET
    ACS Nano; 2019 Jan; 13(1):143-151. PubMed ID: 30525446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of Nanosized Pharmaceutical Formulations by Dual Centrifugation.
    Koehler JK; Schmager S; Bender V; Steiner D; Massing U
    Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardium-Derived Cells Formed After Myocardial Injury Display Phagocytic Activity Permitting In Vivo Labeling and Tracking.
    Ding Z; Temme S; Quast C; Friebe D; Jacoby C; Zanger K; Bidmon HJ; Grapentin C; Schubert R; Flögel U; Schrader J
    Stem Cells Transl Med; 2016 May; 5(5):639-50. PubMed ID: 27057005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous-Flow Production of Perfluorocarbon-Loaded Polymeric Nanoparticles: From the Bench to Clinic.
    Hoogendijk E; Swider E; Staal AHJ; White PB; van Riessen NK; Glaßer G; Lieberwirth I; Musyanovych A; Serra CA; Srinivas M; Koshkina O
    ACS Appl Mater Interfaces; 2020 Nov; 12(44):49335-49345. PubMed ID: 33086007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell Labeling for 19F MRI: New and Improved Approach to Perfluorocarbon Nanoemulsion Design.
    Patel SK; Williams J; Janjic JM
    Biosensors (Basel); 2013 Sep; 3(3):341-59. PubMed ID: 25586263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.